CommercialDocumentationMedium impact
11.14.07y, Intra-Articular Injection of Hyaluronan for the Treatment of Osteoarthritis
Independence Blue Cross·Orthopedics, Rheumatology, Physical Therapy +1 more·Pharmacy
Effective date
Dec 1, 2025
We identified it
Jun 19, 2026
Summary
Policy 11.14.07y updates medical necessity criteria for intra-articular hyaluronan injections in osteoarthritis treatment, effective December 1, 2025. Billing teams must verify that claims meet new clinical criteria before submission to avoid denials. Specific coverage requirements and affected HCPCS codes are not detailed in the provided policy excerpt.
Action Required
By December 1, 2025: Billing team must obtain and review the complete policy text for 11.14.07y from the provided source URL to identify specific medical necessity criteria, HCPCS codes (likely J-codes for hyaluronan products), and any prior authorization requirements. Update billing system rules and provider documentation templates to enforce new criteria. Coordinate with clinical staff to ensure providers document medical necessity according to updated standards. Claims submitted without proper documentation of medical necessity will be denied.